The relevance of long-acting injectables in the treatment of schizophrenia
- PMID: 36716760
- DOI: 10.1016/S2215-0366(23)00033-0
The relevance of long-acting injectables in the treatment of schizophrenia
Conflict of interest statement
MH reports honoraria for lecture from Otsuka and advisory board participation for Rovi. SCR reports advisory board participation for Recordati, Otsuka, and Janssen.
Comment on
-
Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies.Lancet Psychiatry. 2021 May;8(5):387-404. doi: 10.1016/S2215-0366(21)00039-0. Epub 2021 Apr 13. Lancet Psychiatry. 2021. PMID: 33862018
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical